Gene Editing and the Slippery Slope Argument: Should We Fix the Enhancement/Therapy Distinction as the Definitive Boundary?

  • Iñigo de Miguel Beriain


  1. De Miguel Beriain, I. (2017). Legal issues regarding gene editing at the beginning of life: An EU perspective. Regenerative Medicine, 12(6), 669–679.CrossRefGoogle Scholar
  2. Walton, D. (2016). The slippery slope argument in the ethical debate on genetic engineering of humans. Science and Engineering Ethics, 23(6), 1507–1528.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V., part of Springer Nature 2018

Authors and Affiliations

  1. 1.G.I. Cátedra de Derecho y Genoma Humano, Departamento de Derecho PúblicoUniversity of the Basque Country. UPV/EHULeioaSpain
  2. 2.IKERBASQUE, Basque Foundation for ScienceBilbaoSpain

Personalised recommendations